UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 349

Sortiert nach

Erratum to: Optimizing the Aging Brain: The BEAD Study on the Ethics of Dementia Prevention

Journal of Frailty & Aging, 2023, Vol.12 (3), p.253-253

2023

Volltextzugriff (PDF)

Optimizing the Aging Brain: The BEAD Study on the Ethics of Dementia Prevention

Journal of Frailty & Aging, 2023, Vol.12 (2), p.111-116

2023

Volltextzugriff (PDF)

Why genes are like lemons

Studies in history and philosophy of science. Part C, Studies in history and philosophy of biological and biomedical sciences, 2016-06, Vol.57, p.88-95

2016

Volltextzugriff (PDF)

Low glomerular filtration rate is a risk factor for ribavirin-associated anaemia in old patients with chronic hepatitis C

Journal of viral hepatitis, 2013-04, Vol.20 (4), p.e90-e95

2013

Volltextzugriff (PDF)

909 IMPACT OF DEMOGRAPHIC CHARACTERISTICS ON RESPONSE TO PEGYLATED INTERFERON/RIBAVIRIN TREATMENT IN GENOTYPE 2 AND 3 CHC PATIENTS

Journal of hepatology, 2013-04, Vol.58, p.S374-S375

2013

Volltextzugriff (PDF)

1161 ESTIMATED RIBAVIRIN CONCENTRATION IS THE FACTOR MOST INFLUENCING THE EARLY ONSET OF ANEMIA DURING PEG-IFN PLUS RIBAVIRIN THERAPY IN OLD (>50 YEARS) G1 CHC PATIENTS

Journal of hepatology, 2012-04, Vol.56, p.S459-S459

2012

Volltextzugriff (PDF)

Sédation-analgésie en réanimation (nouveau-né exclu)

Annales françaises d'anesthésie et de réanimation, 2008-07, Vol.27 (7), p.541-551

2008

Volltextzugriff (PDF)

Des clowns en unité Alzheimer

NPG, 2011-12, Vol.11 (66), p.264-267

2011

Volltextzugriff (PDF)

P.18.7 IMPACT OF AGE AND SEX ON RESPONSE TO THERAPY WITH PEGYLATED INTERFERON PLUS RIBAVIRIN IN GENOTYPE 2 AND 3 CHRONIC HEPATITIS C PATIENTS

Digestive and liver disease, 2013-03, Vol.45, p.S212-S212

2013

Volltextzugriff (PDF)

664 ACUTE B HEPATITIS AFTER TRANSFUSION OF RED BLOOD CELLS FROM A DONOR WITH OCCULT HEPATITIS B VIRUS INFECTION

Journal of hepatology, 2010, Vol.52, p.S259-S259

2010

Volltextzugriff (PDF)

P.04.14 ESTIMATED SERUM RIBAVIRIN CONCENTRATION PREDICTS THE EARLY ONSET OF RIBAVIRIN-INDUCED ANEMIA IN ELDERLY PATIENTS WITH GENOTYPE-1 CHRONIC HEPATITIS C

Digestive and liver disease, 2012-03, Vol.44, p.S109-S110

2012

Volltextzugriff (PDF)

T-11 5-year entecavir in NUC-naïve, field-practice patients with CHB showed excellent viral suppression and safety but no prevention of HCC

Digestive and liver disease, 2013-02, Vol.45, p.S16-S16

2013

Volltextzugriff (PDF)

P.15.2 ENTECAVIR MONOTHERAPY IN 418 NUC-NAIVE PATIENTS WITH CHRONIC HEPATITIS B FROM FIELD PRACTICE: HIGH EFFICACY AND FAVORABLE SAFETY PROFILE OVER 3 YEARS OF TREATMENT

Digestive and liver disease, 2012-03, Vol.44, p.S184-S185

2012

Volltextzugriff (PDF)

OC.07.1 2-YEAR EFFECTIVENESS AND SAFETY OF TENOFOVIR IN 302 NUC-NAIVE PATIENTS WITH CHRONIC HEPATITIS B: A MULTICENTER EUROPEAN STUDY IN CLINICAL PRACTICE

Digestive and liver disease, 2012-03, Vol.44, p.S70-S70

2012

Volltextzugriff (PDF)

P.1.41: REDUCED RENAL FUNCTION IS ASSOCIATED WITH ANEMIA DURING TREATMENT WITH PEGINTERFERON/RIBAVIRIN IN ELDERLY CHRONIC HEPATITIS C PATIENTS

Digestive and liver disease, 2011, Vol.43, p.S162-S162

2011

Volltextzugriff (PDF)

T-9 2-year effectiveness and safety of tenofovir in 302 NUC-naive patients with chronic hepatitis B: a multicenter European study in clinical practice

Digestive and liver disease, 2012-02, Vol.44, p.S16-S17

2012

Volltextzugriff (PDF)

T-8 Entecavir monotherapy in 418 NUC-naive patients with chronic hepatitis B from field practice: high efficacy and favorable safety profile over 3 years of treatment

Digestive and liver disease, 2012-02, Vol.44, p.S16-S16

2012

Volltextzugriff (PDF)

Severe liver fibrosis or cirrhosis: accuracy of US for detection--analysis of 300 cases

Radiology, 2003-04, Vol.227 (1), p.89

2003

Volltextzugriff (PDF)

T-35 In CHC patients aged =50 years ribavirin-induced anemia depends on renal function

Digestive and liver disease, 2011, Vol.43, p.S88-S88

2011

Volltextzugriff (PDF)

1 – 25 von 349

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(301)
Mit Volltextzugriff
(312)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(174)
Life Sciences & Biomedicine
(156)
Humans
(110)
Life Sciences
(96)
Animals
(85)
Biological And Medical Sciences
(61)
Female
(59)
Male
(56)
Virology
(53)
Infectious Diseases
(46)
Medical Sciences
(45)
Adult
(36)
Sheep
(36)
Gastroenterology And Hepatology
(35)
Fundamental And Applied Biological Sciences. Psychology
(34)
Microbiology
(33)
Middle Aged
(32)
Mice
(31)
Cattle
(25)
Viral Diseases
(25)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Erratum to: Optimizing the Aging Brain: The BEAD Study on the Ethics of Dementia Prevention

Optimizing the Aging Brain: The BEAD Study on the Ethics of Dementia Prevention

Why genes are like lemons

Low glomerular filtration rate is a risk factor for ribavirin-associated anaemia in old patients with chronic hepatitis C

909 IMPACT OF DEMOGRAPHIC CHARACTERISTICS ON RESPONSE TO PEGYLATED INTERFERON/RIBAVIRIN TREATMENT IN GENOTYPE 2 AND 3 CHC PATIENTS

1161 ESTIMATED RIBAVIRIN CONCENTRATION IS THE FACTOR MOST INFLUENCING THE EARLY ONSET OF ANEMIA DURING PEG-IFN PLUS RIBAVIRIN THERAPY IN OLD (>50 YEARS) G1 CHC PATIENTS

Sédation-analgésie en réanimation (nouveau-né exclu)

755 5-YEAR ENTECAVIR TREATMENT IN NUC-NAÏVE, FIELD-PRACTICE PATIENTS WITH CHRONIC HEPATITIS B SHOWED EXCELLENT VIRAL SUPPRESSION AND SAFETY PROFILE BUT NO PREVENTION OF HCC IN CIRRHOTICS

Des clowns en unité Alzheimer

P.18.7 IMPACT OF AGE AND SEX ON RESPONSE TO THERAPY WITH PEGYLATED INTERFERON PLUS RIBAVIRIN IN GENOTYPE 2 AND 3 CHRONIC HEPATITIS C PATIENTS

522 MAINTAINED VIRAL SUPPRESSION AND EXCELLENT SAFETY PROFILE OF ENTECAVIR MONOTHERAPY IN 418 NUC-NAÏVE PATIENTS WITH CHRONIC HEPATITIS B: A 4-YEAR FIELD PRACTICE, MULTICENTER STUDY

525 TENOFOVIR MONOTHERAPY FOR NAÏVE PATIENTS WITH CHRONIC HEPATITIS B: A MULTICENTER EUROPEAN STUDY IN CLINICAL PRACTICE IN 302 PATIENTS FOLLOWED FOR 30 MONTHS

664 ACUTE B HEPATITIS AFTER TRANSFUSION OF RED BLOOD CELLS FROM A DONOR WITH OCCULT HEPATITIS B VIRUS INFECTION

Four years of tenofovir monotherapy for NUC naïve field practice European patients suppresses HBV replication in most patients with a favorable renal safety profile but does not prevent HCC in patients with or without cirrhosis

P.04.14 ESTIMATED SERUM RIBAVIRIN CONCENTRATION PREDICTS THE EARLY ONSET OF RIBAVIRIN-INDUCED ANEMIA IN ELDERLY PATIENTS WITH GENOTYPE-1 CHRONIC HEPATITIS C

731 EFFECTIVENESS AND SAFETY OF TENOFOVIR DISOPROXIL FUMARATE IN FIELD PRACTICE: A MULTICENTER EUROPEAN COHORT STUDY OF 302 NUC-NAIVE PATIENTS WITH CHRONIC HEPATITIS B

T-11 5-year entecavir in NUC-naïve, field-practice patients with CHB showed excellent viral suppression and safety but no prevention of HCC

T-12 Tenofovir suppressed viral suppression in most field practice, treatment-naïve patients with CHB followed for 3 years in a multicenter European study

P.15.2 ENTECAVIR MONOTHERAPY IN 418 NUC-NAIVE PATIENTS WITH CHRONIC HEPATITIS B FROM FIELD PRACTICE: HIGH EFFICACY AND FAVORABLE SAFETY PROFILE OVER 3 YEARS OF TREATMENT

OC.07.1 2-YEAR EFFECTIVENESS AND SAFETY OF TENOFOVIR IN 302 NUC-NAIVE PATIENTS WITH CHRONIC HEPATITIS B: A MULTICENTER EUROPEAN STUDY IN CLINICAL PRACTICE

P.1.41: REDUCED RENAL FUNCTION IS ASSOCIATED WITH ANEMIA DURING TREATMENT WITH PEGINTERFERON/RIBAVIRIN IN ELDERLY CHRONIC HEPATITIS C PATIENTS

T-9 2-year effectiveness and safety of tenofovir in 302 NUC-naive patients with chronic hepatitis B: a multicenter European study in clinical practice

T-8 Entecavir monotherapy in 418 NUC-naive patients with chronic hepatitis B from field practice: high efficacy and favorable safety profile over 3 years of treatment

Severe liver fibrosis or cirrhosis: accuracy of US for detection--analysis of 300 cases

T-35 In CHC patients aged =50 years ribavirin-induced anemia depends on renal function

Suchergebnisse filtern